#United States #Scottsdale #Women Health #Mayo Clinic #Pause Technologies

The Pause Technologies Completes Participation in the 2025 Mayo Clinic and ASU MedTech Accelerator

On April 2, 2025, The Pause Technologies announced its successful conclusion in the highly competitive Mayo Clinic and Arizona State University MedTech Accelerator program. Out of numerous hopeful applicants worldwide, only ten companies secured a spot in the 2025 cohort, with The Pause Technologies being the sole female-founded participant. This achievement highlights the company's commitment to redefining menopause support through innovative technology.

Founded with the goal of transforming the experience of menopause, The Pause Technologies offers an advanced, real-time AI platform that serves women going through this significant life transition. Their proprietary service, known as thePause™, provides users with round-the-clock symptom management, biometric feedback integration, and clinical-grade insights, all aimed at simplifying the way women manage their health during perimenopause and menopause.

The Mayo Clinic and ASU MedTech Accelerator program is recognized as one of the most selective initiatives globally for emerging medical technology firms. By participating, companies gain access to unparalleled clinical, academic, and commercial expertise, enabling them to fine-tune their solutions for real-world impact.

Susan Sly, the CEO and Founder of The Pause Technologies, articulated the urgency of addressing the gaps in women's health care. She emphasized, “The current healthcare system often neglects the unique experiences of women in midlife. A recent special featuring Oprah highlighted the seriousness of menopause symptoms and their widespread dismissal in healthcare discussions. This accelerator experience validates our mission to provide intelligent and immediate assistance to women dealing with menopause, reinforcing the need for dedicated solutions.”

As per estimates from Forbes, over one billion women are anticipated to enter menopause globally by 2030. This statistic reinforces the growing demand for innovative approaches to support women's health during this phase. The Pause Technologies aims to meet this increasing need with their adaptive platform, which empowers women to comprehend and manage their health effectively.

Dr. Mia Chorney, Co-Founder and Chief Medical Officer at The Pause Technologies, pointed out the existing stigma and misinformation surrounding menopause. “Menopause care is often reactive and lacks proactive strategies. Our participation in this accelerator allowed us to enhance our clinical validation and refine our technological framework with input from leading experts in the field. Our vision is to embark on a journey where menopause is no longer perceived as a burden but as a phase of life supported by compassionate and intelligent technology.”

The company is actively working to forge partnerships with healthcare enterprises, wellness providers, and clinical researchers to broaden the accessibility and efficacy of its solutions.

To discover more about The Pause Technologies and its innovative AI-driven platform for menopause support, visit www.thepause.ai.

About The Pause Technologies

The Pause Technologies is at the forefront of women’s health innovation with a proprietary AI platform tailored to assist women navigating perimenopause and menopause. Founded by esteemed AI entrepreneur Susan Sly, thePause™ provides personalized, intelligent, and real-time support to empower women through hormonal transitions. Headquartered in Scottsdale, Arizona, The Pause Technologies is not just a technology company; it’s a mission-driven organization dedicated to transforming the menopause experience for women around the globe.